Back to Agenda
The Voice of the Patient – Innovative Ways of Patient Engagement in R&D
Session Chair(s)
Jan Geissler, MBA
Managing Director
Patvocates, Germany
Matthias Gottwald
Head R&D Policy and Networking
Bayer Pharma AG, Germany
This session will look into novel approaches for patient engagement in R&D and discuss opportunities and challenges of this innovative partnership from different stakeholder perspectives.
Speaker(s)
The Patient’s View
Alastair Kent, MHS
Genetic Alliance UK, United Kingdom
Co-Chair of the UK Rare Disease Policy Board; Former Executive Director
The Industry View
Anton Hoos, MD, PhD, MBA
Patient Focused Medicine Development, Belgium
Executive Team
The Regulator View
Birka Lehmann, MD
Birka Lehmann, Germany
Senior Expert Drug Regulatory Affairs
Have an account?